EQ
Equillium Inc
NASDAQ: EQ · HEALTHCARE · BIOTECHNOLOGY
$2.08
+1.46% today
Updated 2026-04-29
Market cap
$136.57M
P/E ratio
—
P/S ratio
20.22x
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$0 – $3
Volume
0.5M
WallStSmart proprietary scores
21
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$6.38
+206.73%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-3.18M
- Revenue declining -52.30% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $15.76M | $36.08M | $41.09M | $130000.00 | $4.39M |
| Net income | $-62.43M | $-13.34M | $-8.07M | $-22.40M | $-3.77M |
| EPS | — | — | — | — | $-0.39 |
| Free cash flow | $-9.01M | $-21.83M | $-19.11M | $-22.79M | $-3.18M |
| Profit margin | -396.14% | -36.96% | -19.63% | -17,229.23% | — |
Peer comparison
Smart narrative
Equillium Inc trades at $2.08. Our Smart Value Score of 21/100 indicates the stock is weak. TTM revenue stands at $4.39M.
Frequently asked questions
What is Equillium Inc's stock price?
Equillium Inc (EQ) trades at $2.08.
Is Equillium Inc overvalued?
Smart Value Score 21/100 (Grade F, Strong Sell).
What is the price target of Equillium Inc (EQ)?
The analyst target price is $6.38, representing +206.7% upside from the current price of $2.08.
What is Equillium Inc's revenue?
TTM revenue is $4.39M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio20.22x
ROE-94.00%
Beta1.74
50D MA$1.95
200D MA$1.39
Shares out0.06B
Float0.03B
Short ratio—
Avg volume0.5M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—